Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9524]
News [23370]
Articles [1991]
Editorials [134]
Conferences [465]
elearning [298]
ESMO Session: Ovarian cancer: new biology, new targets
ESMO Session: Ovarian cancer: new biology, new targets
ESMO 2010: First-line FOLFIRI improves time to treatment failure versus standard therapy for advanced gastric cancer
ESMO 2010: First-line FOLFIRI improves time to treatment failure versus standard therapy for advanced gastric...
ESMO 2010: "Nothing about us without us"
ESMO 2010: "Nothing about us without us"
ESMO 35: Final results from landmark trial confirm survival benefits of EGFR mutations in lung cancer
ESMO 35: Final results from landmark trial confirm survival benefits of EGFR mutations in lung cancer
What's new for ipilimumab? Report from ESMO 2010
What's new for ipilimumab? Report from ESMO 2010
Denosumab update from ESMO 2010
Denosumab update from ESMO 2010
ESMO Session: Targeted agents in prostate cancer – Changing the paradigms
ESMO Session: Targeted agents in prostate cancer – Changing the paradigms
ESMO Session: Breast cancer challenges in the setting of curable disease
ESMO Session: Breast cancer challenges in the setting of curable disease
ESMO 35: Fertility concerns of cancer survivors inadequately addressed, study finds
ESMO 35: Fertility concerns of cancer survivors inadequately addressed, study finds
ESMO 35: New Phase II study shows first-line promise of lung cancer drug PF-299
ESMO 35: New Phase II study shows first-line promise of lung cancer drug PF-299

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation